The START Center for Cancer Research
Sachenka Pichardo is an accomplished technology delivery expert currently serving as the Director of Technology Delivery at The START Center for Cancer Research since June 2024. With extensive experience in technology delivery management, Pichardo has been instrumental in developing a technology delivery organization at Alcority, focusing on significant enterprise initiatives. As the founder of Pichardo Engineers, an advisory firm established in 2013, Pichardo provided comprehensive support for entrepreneurs in operations, growth, and risk management. Previous roles include significant contributions at Dorilton Capital, Prudential Financial, and Horizon Blue Cross Blue Shield, highlighting expertise in program and project management across various sectors. Pichardo holds an MBA in Organizational Leadership from New York University's Leonard N. Stern School of Business and a Bachelor's degree in Computer Engineering from the New Jersey Institute of Technology.
This person is not in any teams
The START Center for Cancer Research
1 followers
Deeply rooted in community oncology centers globally, the START Center for Cancer Research provides patients with access to specialized Phase 1 clinical trials for novel anti-cancer agents. With research sites in the United States and in Spain, Portugal, and Ireland, START’s clinical trial sites have conducted more than 1,300 early phase clinical trials, including for 43 therapies that have gained FDA/EMA approval. Founded in Texas in 2007, START today boasts 25 Principal Investigators (PIs) across its worldwide clinical trial sites. With over 100,000+ square feet of world-class research facilities, START offers patients comprehensive treatment plans that include multi-specialty services, genetic profiling of tumors, targeted therapies, state-of-the-art treatment technology, and advanced access to clinical research options. START is committed to accelerating passage from trials to treatments, and to delivering hope to patients, families, and physicians around the world.